Breaking News Instant updates and real-time market news.

MU

Micron

$17.73

-0.05 (-0.28%)

, QCOM

Qualcomm

$67.11

-1.39 (-2.03%)

15:02
10/04/16
10/04
15:02
10/04/16
15:02

On The Fly: What to watch in Micron earnings report

Micron (MU) is scheduled to report results of its fourth fiscal quarter after the market close on October 4, with a conference call scheduled for 4:30 pm ET. What to watch for: 1. POSITIVE PRE-ANNOUNCEMENT: In early September, Micron said at a tech conference hosted by Citigroup that revenue for the fourth quarter is expected to meet the upper end of its $2.9B-$3.2B guidance provided in its last earnings report. About a month later, Evercore ISI analyst C.J. Muse said that the positive pre-announcement was "just the start" of a meaningful cyclical recovery for Micron. The analyst noted that the company's many technology transitions are coinciding with a period of tightening supply and increasing prices. Muse added that investors should "expect more good news ahead" for Micron and maintained a Buy rating with a $25 price target on the stock. 2. RESTRUCTURING PLAN: Along with its last earnings report, Micron announced a restructuring plan in response to the "current business environment" and the need to shift focus toward key priorities. The company at the time said it intends to implement a cost savings program in which it expects to save roughly $80M per quarter in fiscal 2017 and anticipates incurring charges associated with the plan of $70M, mostly in cash expenditures, the majority of which is expected to be incurred in the fourth quarter of 2016. Micron noted at the time that the savings are expected to come from a combination of more focused projects and programs, the permanent closure of a number of open headcount requisition, job cuts in certain areas, and other spending reductions. 3. MORGAN SEES NOVEMBER QUARTER UPSIDE: Commenting on Micron's next quarter, Morgan Stanley analyst Joseph Moore said that, while Micron's guidance for November will likely be conservative, the firm anticipates "substantial" November quarter upside to emerge over the next three months. The analyst said the firm recommends investors to continue buying the stock given the strong pricing backdrop and strong Dynamic Random Access Memory, or DRAM, bit growth the last two quarters, which should drive an earnings inflection higher. Moore added that he sees upside to Q1 numbers and an upward revision to his FY17 $1.22 estimates as he sees DRAM pricing continuing to be strong, with NAND a bit more mixed, for the next several quarters. The analyst rates Micron a Buy with a $20 price target on shares. 4. QUALCOMM-NXP DEAL TALKS: Last Thursday, the Wall Street Journal reported that Qualcomm (QCOM) was in discussions to acquire NXP Semiconductors (NXPI), according to people familiar with the matter. Such a deal would likely be valued at over $30B and could be reached in the next two to three months, the Journal added. Several of other companies in the semiconductor space moved to their best levels of the session last Thursday following the report, including Micron, AMD (AMD), Intel (INTC), Marvell (MRVL), Microchip (MCHP), NVIDIA (NVDA), and Texas Instruments (TXN).

MU

Micron

$17.73

-0.05 (-0.28%)

QCOM

Qualcomm

$67.11

-1.39 (-2.03%)

NXPI

NXP Semiconductors

$102.76

0.75 (0.74%)

AMD

AMD

$6.95

0.04 (0.58%)

INTC

Intel

$37.66

-0.09 (-0.24%)

MRVL

Marvell

$13.02

-0.25 (-1.88%)

MCHP

Microchip

$61.82

-0.32 (-0.51%)

NVDA

Nvidia

$68.45

-0.07 (-0.10%)

TXN

Texas Instruments

$69.66

-0.52 (-0.74%)

  • 04

    Oct

  • 08

    Nov

  • 14

    Nov

MU Micron
$17.73

-0.05 (-0.28%)

09/29/16
NOMU
09/29/16
NO CHANGE
Target $23
NOMU
Buy
Nomura remains a Buyer of Micron, especially on weakness
Nomura analyst Romit Shah believes we are in the early part of a positive earnings revision cycle for Micron. The analyst raised his November earnings estimate to 17c, above consensus of 8c, but below "perceived" consensus of 20c-25c. Shah said DRAM's pricing outlook is the key driver as pricing and mix are improving. The analyst remains a buyer of Micron and reiterates his Buy rating and $23 price target.
10/03/16
MSCO
10/03/16
NO CHANGE
MSCO
Overweight
Morgan Stanley continues to recommend buying Micron
Morgan Stanley analyst Joseph Moore recommends to continue buying Micron given the strong pricing backdrop and strong DRAM bit growth the last 2 quarters, which should drive an earnings inflection higher. Moore sees upside to Q1 numbers and an upward revision to his FY17 $1.22 estimate as he expects DRAM pricing to remain strong, with NAND a bit more mixed, for the next several quarters. The analyst is not making a trade into tomorrow's report due to lack of transparency into guidance, but recommends buying shares into a strong November quarter and beyond. Moore rates Micron a Buy with a $20 price target on shares.
09/16/16
CLVD
09/16/16
UPGRADE
CLVD
Buy
Micron upgraded to Buy on sustainable DRAM and NAND at Cleveland Research
As previously reported, Cleveland Research upgraded Micron to Buy from Neutral. Analyst Kevin Rottinghaus said Micron's execution has improved and progress in DRAM and NAND fundamentals over the past 2-3 months is sustainable into 2017. He sees several catalysts over the next 12 months including DRAM demand outpacing bit supply growth for CY17, improved DRAM demand outlook for computing, data center, and mobile, improving execution at 20nm, Micron appearing to be second to market with 3D SSD solutions, and NAND expected to be in tight supply through 2017. Rottinghaus expects additional material positive estimate revisions over the next 6+ months.
09/16/16
09/16/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) coverage assumed with an Outperform from Neutral at Credit Suisse with analyst Edward Kelly saying he is encouraged by Wal-Mart's return to traffic growth against a deteriorating staples retail environment and its aggressive U.S. investments to solidify its position in an evolving industry. 2. Clorox (CLX) upgraded to Overweight from Neutral at Atlantic Equities. 3. Comerica (CMA) upgraded to Conviction Buy from Neutral at Goldman with analyst Ryan Nash saying he sees upside to Comerica's current recently announced strategic plan to improve pre-tax returns by $230M. 4. Hormel Foods (HRL) upgraded to Buy from Hold at Edward Jones. 5. Micron (MU) upgraded to Buy from Neutral at Cleveland Research with analyst Kevin Rottinghaus saying Micron's execution has improved and progress in DRAM and NAND fundamentals over the past 2-3 months is sustainable into 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
QCOM Qualcomm
$67.11

-1.39 (-2.03%)

09/30/16
09/30/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded on potential NXP Semiconductors acquisition at Mizuho with the firm's analyst saying he believes a Qualcomm acquisition of NXP Semiconductors (NXPI) makes significant strategic and financial sense. 2. Skechers (SKX) upgraded to Positive from Neutral at Susquehanna. 3. Sprouts Farmers Markets (SFM) upgraded to Buy from Hold at Jefferies with analyst Christopher Mandeville saying the risk/reward is now favorable following the recent pullback in the shares. 4. Phillips 66 (PSX) upgraded to Neutral from Sell at Goldman with analyst Neil Mehta citing higher multiple assumptions for midstream and chemicals segments, reduced capex spending and higher free cash flow estimates, and more achievable consensus expectations. 5. NetApp (NTAP) upgraded to Buy from Sell at Summit Redstone with analyst Srini Nandury citing optimism that the company can grow its product revenue from current levels driven by AFA sales and increasing adoption of clustered ONTAP. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/30/16
OPCO
09/30/16
NO CHANGE
OPCO
NXP 'cheap' for Qualcomm even after rally, says Oppenheimer
Oppenheimer analyst Rick Schafer says NXP Semiconductors (NXPI) still a "cheap" takeover target for Qualcomm (QCOM) even after rallying 25% over the past two days. An acquisition would be accretive to Qualcomm's earnings "under most scenarios," the analyst tells investors in an intraday research note. He thinks Qualcomm needs to diversify away from handsets and has $31B of offshore cash, the analyst contends. Schafer keeps a Perform rating on Qualcomm.
10/03/16
UBSW
10/03/16
NO CHANGE
Target $59
UBSW
Neutral
Qualcomm acquisition of NXP Semiconductors would be positive, says UBS
UBS analyst Stephen Chin said he would view an acquisition of NXP Semiconductors (NXPI) by Qualcomm (QCOM) as positive citing such a deals likely accretion, as well as benefits like sales diversification, its patent portfolio and cash flow generation. Chin maintains his Neutral rating and $59 price target on Qualcomm shares.
10/03/16
RBCM
10/03/16
NO CHANGE
Target $70
RBCM
Sector Perform
RBC says $120-130/share seems like high end of reasonable Qualcomm price for NXP
RBC analyst Amit Daryanani believes $120-$130 per share is likely the "upper end of the valuation framework" that Qualcomm (QCOM) would like to pay in any potential deal to acquire NXP Semiconductors (NXPI). While Qualcomm "can certainly elect to pay a larger premium" than that, doing so would likely come in the form of Qualcomm equity issuance, which would impede the accretion from the deal, Daryanani tells investors. The analyst keeps a Sector Perform rating on Qualcomm shares, but raised his price target on the stock to $70 from $59 citing the potential for diversification and higher cash flow generation that an NXP deal would provide.
NXPI NXP Semiconductors
$102.76

0.75 (0.74%)

09/30/16
RHCO
09/30/16
NO CHANGE
RHCO
NXP Semiconductors could be acquired for $124 per share, says SunTrust
After Dow Jones reported that NXP (NXPI) is in talks to be bought by Qualcomm (QCOM) for more than $95 per share, SunTrust analyst William Stein says that, based on recent takeover valuations in the semiconductor space, NXP would be acquired for $124 per share. The analyst says that NXP is worth $104 per share on a standalone basis, and he does not expect the company to sell itself for $95. Stein adds that NXP would improve Qualcomm's efforts in NFC and automotive. He expects NXP's stock to rise whether or not a deal is made, and he keeps a Buy rating on the shares.
AMD AMD
$6.95

0.04 (0.58%)

09/20/16
SUSQ
09/20/16
INITIATION
Target $6.5
SUSQ
Neutral
AMD initiated with a Neutral at Susquehanna
Susquehanna analyst Christopher Rolland initiated AMD with a Neutral and a $6.50 price target due to valuation.
09/20/16
BERN
09/20/16
UPGRADE
BERN
AMD upgraded to Market Perform from Underperform at Bernstein
09/20/16
09/20/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ford (F) initiated with a Buy at Nomura. 2. Intel (INTC) was initiated with a Positive at Susquehanna while the firm initiated AMD (AMD) with a Neutral. 3. HSN, Inc. (HSNI) initiated with an Underperform at BofA/Merrill. 4. Bojangles (BOJA) initiated with a Strong Buy at CL King. 5. D.R. Horton (DHI) initiated with an Outperform at Wedbush. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/20/16
09/20/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Betsy Graseck saying shares are trading at a 11 times Price/Earnings for a 3.5% yield, and is one of the "best values" in the S&P 1500 and the sector. 2. Tech Data (TECD) was upgraded to Buy from Hold at Stifel, to Buy from Underperform at CLSA, and to Buy from Neutral at BofA/Merrill. 3. AMD (AMD) upgraded to Market Perform from Underperform at Bernstein. 4. Diamond Offshore (DO) upgraded to Buy from Hold at Evercore ISI with analyst James West saying he believes the offshore rig market will bottom over the next 6-12 months and notes shares are down approximately 42% from its mid-July peak. 5. BHP Billiton (BHP) upgraded to Outperform from Neutral at Macquarie with analyst Alon Olsha citing an increase in coal/manganese forecasts. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
INTC Intel
$37.66

-0.09 (-0.24%)

09/20/16
SUSQ
09/20/16
INITIATION
Target $42
SUSQ
Positive
Intel initiated with a Positive at Susquehanna
Susquehanna analyst Christopher Rolland initiated Intel with a Positive and a $42 price target saying the company has the ability to extract value through process leadership and the best wafer manufacturing in the world.
09/20/16
BMUR
09/20/16
NO CHANGE
Target $40
BMUR
Buy
Intel guidance raise not a surprise, says Brean Capital
Brean Capital analyst Mike Burton noted Intel raised its guidance last week citing the replenishment of the PC supply chain inventory and improving PC demand. The analyst said he was not surprised by the announcement given anecdotal positive data from many of the suppliers in the sector. Burton believes Intel remains well positioned and so reiterated his Buy rating and increased his price target to $40 from $38 on Intel shares.
09/20/16
ADAM
09/20/16
NO CHANGE
Target $44
ADAM
Buy
Intel price target raised to $44 from $40 at Canaccord
Canaccord analyst Matthew Ramsay raised his price target on Intel to $44 from $40 following the company's positive pre-announcement. The analyst increased his estimates as well and said with its attractive dividend yield and valuation, Intel should be a core holding for investors. Ramsay reiterated his Buy rating on Intel shares.
MRVL Marvell
$13.02

-0.25 (-1.88%)

09/20/16
SUSQ
09/20/16
INITIATION
Target $13
SUSQ
Neutral
Marvell initiated with a Neutral at Susquehanna
Susquehanna analyst Christopher Rolland initiated Marvell with a Neutral and a $13 price target due to valuation and an aged product portfolio.
09/07/16
GSCO
09/07/16
INITIATION
Target $12
GSCO
Neutral
Marvell reinstated with a Neutral at Goldman
Goldman analyst Mark Delaney reinstated Marvell with a Neutral and $12 price target. The analyst believes the turnaround will be difficult given high exposure to mature or declining areas like HDDs, printers, enterprise campus switching, and a baseband business being would down, combined with shares at full valuation.
09/07/16
BMUR
09/07/16
NO CHANGE
Target $15
BMUR
Buy
Marvell new strategic plan focuses on core markets, says Brean Capital
Brean Capital analyst Mike Burton said Marvell's new strategic plan is to focus on core markets. The analyst believes a restructuring or major cost cutting initiative is the likely next step toward its goals. Burton is optimistic about the new management team and senses the company guidance is conservative. Burton reiterated his Buy rating and $15 price target on Marvell shares.
09/19/16
CHLM
09/19/16
NO CHANGE
CHLM
Craig-Hallum says to buy Western Digital, Seagate, Marvell and AMD
Craig-Hallum analyst Christian Schwab says to buy Western Digital (WDC), Seagate (STX), Marvell (MRVL), and AMD (AMD) following Intel's (INTC) raised Q3 guidance on PC strength. Schwab believes there is solid demand and a healthy pricing environment in both HDD and NAND.
MCHP Microchip
$61.82

-0.32 (-0.51%)

02/04/16
SPHN
02/04/16
NO CHANGE
Target $55
SPHN
Equal Weight
Microchip sees December quarter as end of inventory correction, says Stephens
Stephens analyst Harsh Kumar noted that along with reporting "solid" December quarter results, Microchip said it believes the quarter marked the end of the current inventory correction. The company historically has credibility in calling semiconductor cycles, Kumar tells investors in a research note. The analyst, who prefers to wait for a better entry point into the stock, keeps a $55 price target and Equal Weight rating on Microchip shares.
05/16/16
LYON
05/16/16
INITIATION
Target $58
LYON
Buy
Microchip initiated with a Buy at CLSA
Target $58.
08/09/16
NEED
08/09/16
NO CHANGE
Target $70
NEED
Buy
Microchip price target raised to $70 from $60 at Needham
Needham analyst Rajvindra Gill raised his price target for Microchip (MCHP) to $70 from $60 following a "significant" quarter beat and raise. The analyst remains confident on the company's long-term earnings power and possible upside over the next several quarters as it folds Atmel's (ATML) operations into its efficient operating model. Gill reiterates a Buy rating on Microship's shares.
09/30/16
MZHO
09/30/16
INITIATION
Target $67
MZHO
Neutral
Microchip initiated with a Neutral at Mizuho
Mizuho initiated Microchip with a Neutral and a $67 price target.
NVDA Nvidia
$68.45

-0.07 (-0.10%)

09/19/16
RHCO
09/19/16
INITIATION
Target $59
RHCO
Neutral
NVIDIA initiated with a Neutral at SunTrust
SunTrust analyst William Stein initiated NVIDIA with a Neutral and a $59 price target saying shares are failry valued.
09/20/16
RHCO
09/20/16
INITIATION
RHCO
Neutral
NVIDIA initiated at SunTrust
As noted earlier, SunTrust initiated NVIDIA with a Neutral rating. Analyst William Stein thinks the stock will be boosted over the long-term by the proliferation of workload acceleration and artificial intelligence in data centers and automobiles. However, he thinks that the company's revenue growth appears to be peaking, as the outlook for its professional visualization, OEM, and IP end markets is negative, according to the analyst. He says that these end markets represent 22% of its sales.
09/20/16
SUSQ
09/20/16
INITIATION
Target $66
SUSQ
Neutral
NVIDIA initiated with a Neutral at Susquehanna
Susquehanna analyst Christopher Rolland initiated NVIDIA with a Neutral and a $66 price target due to valuation.
10/03/16
BOFA
10/03/16
NO CHANGE
Target $80
BOFA
Buy
NVIDIA price target raised to $80 from $72 at BofA/Merrill
BofA/Merrill analyst Vivek Arya raised NVIDIA's price target to $80 from $72 following checks. The analyst said its survey indicates NVIDIA is maintaining an 80% share with its GTX 1060 card with 70% higher content versus last year, Deep Learning could drive upside as emerging applications take hold, and the company has potential $4 in earnings power over the next 3-4 years, higher than his previous $3 estimate. Arya rates NVIDIA a Buy and a top pick.
TXN Texas Instruments
$69.66

-0.52 (-0.74%)

09/13/16
BERN
09/13/16
UPGRADE
BERN
Outperform
Texas Instruments upgraded on margin outlook at Bernstein
As noted earlier, Bernstein upgraded Texas Instruments to Outperform from Market Perform. Analyst Stacy Rasgon says that a number of trends, including a decline in depreciation, improving business mix, and cost reductions, will help enable the company to beat Street margin expectations going forward. Target to $80 from $70.
09/13/16
09/13/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Texas Instruments (TXN) upgraded to Outperform from Market Perform at Bernstein with analyst Stacy Rasgon saying that a number of trends, including a decline in depreciation, improving business mix, and cost reductions, will help enable the company to beat Street margin expectations going forward. 2. Anadarko (APC) upgraded to Buy from Accumulate at Johnson Rice. 3. Viacom (VIAB) upgraded to Buy from Hold at Brean Capital with analyst Alan Gould saying that most, if not all, of the negatives are fully priced into the shares at current levels. 4. Western Digital (WDC) upgraded to Buy from Neutral at Longbow with analyst Joe Wittine saying the company's near-term demand trends are "favorable," while its acquisitions should help boost its bottom line and reduce its debt. 5. Kate Spade (KATE) upgraded to Outperform from Market Perform at Wells Fargo with analyst Ike Boruchow saying the risk/reward is compelling following the recent underperformance of the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/07/16
SBSH
09/07/16
NO CHANGE
Target $75
SBSH
Buy
Texas Instruments unlikely to pursue deal at this time, says Citi
After the company's CFO presented at his firm's Global Technology Conference, Citi analyst Christopher Danely believes Texas Instruments is unlikely to pursue an acquisition at current valuation levels. A deal looks unlikely due to Texas Instruments' preference to repurchase its own shares at similar free cash flow yields given the integration risks of acquiring another company, Danely tells investors in a research note. The analyst keeps a Buy rating on the shares with a $75 price target.
09/12/16
BERN
09/12/16
UPGRADE
BERN
Outperform
Texas Instruments upgraded to Outperform from Market Perform at Bernstein

TODAY'S FREE FLY STORIES

XLNX

Xilinx

$69.33

0.42 (0.61%)

, SNPS

Synopsys

$80.36

0.3 (0.37%)

10:47
09/23/17
09/23
10:47
09/23/17
10:47
Periodicals
Xilinx, Synopsys are 'rising stars' amid natural evolution of AI, Barron's says »

As everyday items get…

XLNX

Xilinx

$69.33

0.42 (0.61%)

SNPS

Synopsys

$80.36

0.3 (0.37%)

CDNS

Cadence Design

$38.88

0.45 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

UTX

United Technologies

$115.01

0.51 (0.45%)

, COL

Rockwell Collins

$130.48

0.09 (0.07%)

10:42
09/23/17
09/23
10:42
09/23/17
10:42
Periodicals
Major aircraft makers, suppliers face off, Barron's says »

While United Technologies…

UTX

United Technologies

$115.01

0.51 (0.45%)

COL

Rockwell Collins

$130.48

0.09 (0.07%)

BA

Boeing

$256.45

0.41 (0.16%)

EADSY

Airbus

$23.06

-0.01 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

GPRO

GoPro

$10.75

-0.19 (-1.74%)

10:33
09/23/17
09/23
10:33
09/23/17
10:33
Periodicals
Key events may create 'short squeeze' in GoPro stock, Barron's says »

GoPro, a heavily shorted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMC

Honda

$29.91

0.18 (0.61%)

, RACE

Ferrari

$113.47

-0.1 (-0.09%)

10:17
09/23/17
09/23
10:17
09/23/17
10:17
Periodicals
Honda $200,000 Acura NSX lacks Ferrari 'raw appeal,' Barron's says »

Acura, Honda's (HMC)…

HMC

Honda

$29.91

0.18 (0.61%)

RACE

Ferrari

$113.47

-0.1 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$48.16

0.19 (0.40%)

10:07
09/23/17
09/23
10:07
09/23/17
10:07
Periodicals
Oracle shares could return 20% in a year, Barron's says »

Oracle is a latecomer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIX

Six Flags

$58.96

1.14 (1.97%)

09:59
09/23/17
09/23
09:59
09/23/17
09:59
Periodicals
Six Flags may have peaked, Barron's says »

Investors have had an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

, AVXS

AveXis

$92.11

-4.03 (-4.19%)

09:51
09/23/17
09/23
09:51
09/23/17
09:51
Periodicals
Gene therapy may be nearing 'major breakthrough,' Baron's says »

Gene therapy is rapidly…

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

AVXS

AveXis

$92.11

-4.03 (-4.19%)

RGNX

Regenxbio

$28.25

-1.15 (-3.91%)

BOLD

Audentes Therapeutics

$27.31

-0.1 (-0.36%)

VYGR

Voyager Therapeutics

$17.50

-0.22 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

  • 22

    Sep

AET

Aetna

$153.57

0.18 (0.12%)

, ANTM

Anthem

$182.86

-0.64 (-0.35%)

09:25
09/23/17
09/23
09:25
09/23/17
09:25
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AET

Aetna

$153.57

0.18 (0.12%)

ANTM

Anthem

$182.86

-0.64 (-0.35%)

CNC

Centene

$92.22

1.48 (1.63%)

CI

Cigna

$182.74

0.61 (0.33%)

HNT

Health Net

HUM

Humana

$239.09

0.45 (0.19%)

MOH

Molina Healthcare

$65.32

2.81 (4.50%)

UNH

UnitedHealth

$193.03

-2.18 (-1.12%)

WCG

WellCare

$167.16

1.1 (0.66%)

AOBC

American Outdoor Brands

$15.01

-0.15 (-0.99%)

RGR

Sturm, Ruger

$51.00

-1.85 (-3.50%)

WMT

Wal-Mart

$79.53

-0.48 (-0.60%)

PEP

PepsiCo

$111.85

-0.95 (-0.84%)

TGT

Target

$58.99

0.66 (1.13%)

AAPL

Apple

$151.89

-1.5 (-0.98%)

MSFT

Microsoft

$74.41

0.2 (0.27%)

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

TWTR

Twitter

$17.61

0.03 (0.17%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

FB

Facebook

$170.54

-0.57 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 10

    Oct

  • 22

    Oct

  • 24

    Oct

  • 08

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

AVA

Avista

$51.40

0.1 (0.19%)

18:47
09/22/17
09/22
18:47
09/22/17
18:47
Hot Stocks
Avista receives commission decision in Oregon natural gas rate case »

Avista's natural gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

BMWYY

BMW

$34.00

0.083 (0.24%)

18:40
09/22/17
09/22
18:40
09/22/17
18:40
Periodicals
BMW to build new 8 series in Dingolfing from 2018, Reuters reports »

BMW intends to build its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$33.37

0.67 (2.05%)

18:20
09/22/17
09/22
18:20
09/22/17
18:20
Hot Stocks
Cisco completes acquisition of Springpath »

Cisco announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 18

    Oct

  • 19

    Oct

  • 22

    Oct

  • 15

    Nov

  • 07

    Dec

  • 11

    Dec

BMY

Bristol-Myers

$63.36

0.03 (0.05%)

18:12
09/22/17
09/22
18:12
09/22/17
18:12
Hot Stocks
Bristol-Myers announces FDA approval of Opdivo »

Bristol-Myers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 18

    Oct

  • 26

    Oct

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

INSE

Inspired Entertainment

$13.60

0.3 (2.26%)

17:38
09/22/17
09/22
17:38
09/22/17
17:38
Hot Stocks
Inspired Entertainment COO Wilson leaving by reason of redundancy »

On September 21, Inspired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MNOV

MediciNova

$6.18

0.3 (5.10%)

17:30
09/22/17
09/22
17:30
09/22/17
17:30
Syndicate
Breaking Syndicate news story on MediciNova »

MediciNova files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ISRG

Intuitive Surgical

$1,031.52

1.31 (0.13%)

17:25
09/22/17
09/22
17:25
09/22/17
17:25
Conference/Events
Intuitive Surgical to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

GD

General Dynamics

$205.41

-0.31 (-0.15%)

17:21
09/22/17
09/22
17:21
09/22/17
17:21
Hot Stocks
General Dynamics Electric Boat awarded $341.2M government contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHRS

Coherus Biosciences

$12.85

0.3 (2.39%)

17:19
09/22/17
09/22
17:19
09/22/17
17:19
Syndicate
Breaking Syndicate news story on Coherus Biosciences »

Coherus Biosciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FIBK

First Interstate

$36.90

0.3 (0.82%)

17:18
09/22/17
09/22
17:18
09/22/17
17:18
Syndicate
First Interstate files to sell $250M of Class A common stock »

The shelf registration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

, NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

17:08
09/22/17
09/22
17:08
09/22/17
17:08
Hot Stocks
National Research launches metric to measure healthcare consumer loyalty »

NRC Health launched the…

NRCIA

National Research, also tag NRCIB

$37.45

0.55 (1.49%)

NRCIB

National Research, also tag NRCIA

$54.30

0.31 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$51.79

-0.16 (-0.31%)

, HON

Honeywell

$141.75

0.89 (0.63%)

16:58
09/22/17
09/22
16:58
09/22/17
16:58
Hot Stocks
Chemours files appeal concerning SNAP 20 rule to regulate HFCs »

The Chemours Company (CC)…

CC

Chemours

$51.79

-0.16 (-0.31%)

HON

Honeywell

$141.75

0.89 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$204.65

1.99 (0.98%)

16:57
09/22/17
09/22
16:57
09/22/17
16:57
Hot Stocks
Allergan receives refusal to file letter from FDA for Vraylar »

Allergan announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

HON

Honeywell

$141.75

0.89 (0.63%)

, CC

Chemours

$51.79

-0.16 (-0.31%)

16:51
09/22/17
09/22
16:51
09/22/17
16:51
Hot Stocks
Honeywell, Chemours seek rehearing of D.C Court decision regarding SNAP program »

Honeywell (HON) and…

HON

Honeywell

$141.75

0.89 (0.63%)

CC

Chemours

$51.79

-0.16 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JOE

Saint Joe Co.

$18.60

0.45 (2.48%)

16:46
09/22/17
09/22
16:46
09/22/17
16:46
Hot Stocks
Breaking Hot Stocks news story on Saint Joe Co. »

Fairholme raises stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
09/22/17
09/22
16:40
09/22/17
16:40
General news
Moody's downgrades UK's rating to Aa2, changes outlook to stable »

Moody's Investors…

A

Agilent

$65.78

-0.14 (-0.21%)

, MRK

Merck

$65.13

-0.47 (-0.72%)

16:36
09/22/17
09/22
16:36
09/22/17
16:36
Hot Stocks
Agilent receives expanded FDA approval for the use of Dako PD-L1 IHC 22C3 »

Agilent Technologies…

A

Agilent

$65.78

-0.14 (-0.21%)

MRK

Merck

$65.13

-0.47 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 26

    Sep

  • 08

    Nov

  • 30

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.